FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21207911000001108: Ondansetron 8mg orodispersible tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Sep 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70679501000001118 Ondansetron 8mg orodispersible tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70679601000001119 Ondansetron 8mg orodispersible tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Is a Ondansetron 8mg orodispersible tablets true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Is a Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug) false Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has specific active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron 8mg orodispersible tablets (Pfizer Ltd) 10 tablet Has AMP True Ondansetron 8mg orodispersible tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start